These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience. Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537 [TBL] [Abstract][Full Text] [Related]
7. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090 [TBL] [Abstract][Full Text] [Related]
8. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis. Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573 [TBL] [Abstract][Full Text] [Related]
9. Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer. Chavarriaga J; Atenafu EG; Mousa A; Langleben C; Anson-Cartwright L; Jewett M; Hamilton RJ Eur Urol Oncol; 2024 Oct; 7(5):1034-1041. PubMed ID: 38278693 [TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients. Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924 [TBL] [Abstract][Full Text] [Related]